塞力医疗: 关于“塞力转债”交易异常波动公告

Core Viewpoint - The company has reported an abnormal fluctuation in the trading of its convertible bonds, "塞力转债," with a cumulative price increase exceeding 30% over three consecutive trading days, prompting a reminder for investors to be cautious about valuation risks [1][7]. Group 1: Convertible Bond Issuance and Trading - The company issued 5.4331 million convertible bonds on August 21, 2020, with a face value of 100 yuan each, totaling 543.31 million yuan [2]. - The initial conversion price for "塞力转债" was set at 16.98 yuan per share, with the conversion period from March 1, 2021, to August 20, 2026 [2]. - The trading price of "塞力转债" reached 175.078 yuan per bond as of July 3, 2025, representing a premium of 75.08% over the face value and a conversion premium rate of 9.65% [1][7]. Group 2: Price Adjustments and Corporate Actions - The company has undergone multiple adjustments to the conversion price of "塞力转债," with the latest adjustment reducing the price from 12.50 yuan to 12.00 yuan per share, effective from February 2025 [5]. - The company confirmed that there are no undisclosed significant events affecting the trading of its convertible bonds, including major asset restructuring or significant transactions [6]. Group 3: Operational Status and Market Environment - The company reported that its production and operational activities are normal, with no significant changes in the market environment or industry policies that could impact the trading of its convertible bonds [6]. - The company has not identified any major events or media reports that could significantly influence the trading price of its convertible bonds [6].